ask="1.19"
ask_size="200"
average_daily_volume="57295"
bid="1.00"
bid_size="5000"
book_value="0.69"
change="-0.01"
change_from_200_day_moving_average="-0.53"
change_from_50_day_moving_average="-0.25"
change_from_52_week_high="-6.91"
change_From_52_week_low="0.12"
change_in_percent="-0.95%"
close="1.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-1.09"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.82"
ex_dividend_date="N/A"
float_shares="7095000"
high="1.07"
high_52_weeks="7.95"
last_trade_date="12/30/2016"
last_trade_price="1.04"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.99"
low_52_weeks="0.92"
market_capitalization="17.05M"
moving_average_200_day="1.57"
moving_average_50_day="1.29"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.00"
open="1.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-33.84%"
percent_change_from_50_day_moving_average="-19.19%"
percent_change_from_52_week_high="-86.92%"
percent_change_from_52_week_low="+13.04%"
previous_close="1.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.51"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.57"
stock_exchange="NGM"
symbol="ORPN"
volume="133330"
weeks_range_52="0.92 - 7.95"
